KEBILIDI
STN: 125722
Proper Name: eladocagene exuparvovec-tneq
Tradename: KEBILIDI
Manufacturer: PTC Therapeutics
Indication:
- For the treatment of adult and pediatric patients with aromatic L amino acid decarboxylase (AADC) deficiency.
Product Information
- Package Insert - KEBILIDI
- Demographic Subgroup Information – eladocagene exuparvovec-tneql - KEBILIDI
Refer to Section 1.1 of the Clinical Review Memo for information about participation in the clinical trials and any analysis of demographic subgroup outcomes that is notable.
Supporting Documents
- November 13, 2024 Approval Letter - KEBILIDI
- November 13, 2024 Summary Basis for Regulatory Action - KEBILIDI
- Approval History, Letters, Reviews, and Related Documents - KEBILIDI